OBI-HUI is the platform pharma commercial and medical affairs teams use to defend their next decision. Eight purpose-built components, specialist agents grounded in named datasets, and an audit log that traces every figure and statement to its source — across two firewalled tenants, on one architecture.
Whether the deliverable is a launch forecast, a digital twin, a publication, or an AdBoard synthesis, the pain is structurally the same. OBI-HUI was built directly against it.
"It's an eight-week Excel build that breaks in two days."
Fourteen linked tabs, a brittle assumption layer, and one analyst who knows where the bodies are buried. When the deal team needs a sensitivity, it starts over.
"The consultants own the work — and the next invoice."
Forecast, digital twin, publication plan, AdBoard synthesis — it leaves the room when they do. You pay again for every refresh, every revision, every scenario. Institutional knowledge never lands in-house.
"Medical content gets stuck behind eight reviewers and a folder no one can find."
Every publication, MIR response, and AdBoard summary loops through MLR with no shared workspace, no provenance trail, and no way to surface the same insight the next time it's needed.
The product sits between your data and your decision. It is opinionated about what to make easy: visual modeling, transparent AI, and provenance on every figure.
Every component on the platform follows the same shell — blocks you can drag, edit, swap, and A/B without rebuilding the model. Whether you're forecasting a launch, modelling a digital twin, or running an AdBoard simulation, the canvas is the same.
No "AI" black box. Each agent has a defined role — sourcing, structuring, synthesising, drafting — a named dataset it reads from, and a human reviewer who signs off before the output enters the model or the document.
Click any number in a model — or any sentence in a medical document — and walk the chain: which agent produced it, which dataset or paper it came from, which assumption or claim was overridden, who signed off, and when. Built for the review you can defend.
Five commercial apps and three behind the firewall in Medical Affairs. Each is a workbench in its own right — and each follows the same shell, the same agent pattern, the same audit log.
A visual revenue-forecasting workbench: patient-flow canvas → segmentation → uptake → price → 10-year trajectory.
Synthetic patient cohorts grounded in RWD, used to stress-test trial designs and commercial assumptions.
Transcripts to theme / quote / sentiment trees, with every claim traceable to the speaker turn.
Compose longitudinal patient cohorts from claims and EMR sources with auditable inclusion criteria.
Map competitor portfolios across indication, mechanism, and segment to surface unaddressed pockets.
Pulls primary literature, trials, and conference proceedings into a structured evidence base with named citations.
Simulate KOL panel responses to a discussion guide, using each KOL's published views and conference history.
Drafts MIR responses, MSL briefings, publications, and congress summaries — every sentence linked to a source.
Every component on the platform follows the same shell: scenario, assumptions, agents, audit trail. Below, the Forecasting workspace running an NSCLC US 10-year forecast — one of eight components, shown here for depth.
Each app on the platform is powered by named, scoped, reviewable agents — never a chatbot. Below, six representative agents: three commercial-side and three behind the firewall in Medical Affairs. Each anchors one of the eight apps, with a named dataset, a structured output, and a human reviewer who signs off.
Selects analog launches matched on indication, mechanism, and market context, and fits an uptake curve with named assumptions and sensitivity bands.
Assembles longitudinal patient-level cohorts from licensed claims and EMR sources, with named inclusion criteria and an auditable derivation chain.
cohort.parquet with patient-month rows and full derivation lineageIngests interview and focus-group transcripts and extracts themes, quotes, and sentiment trees — every claim traceable back to the exact speaker turn.
theme_tree.json with quotes, timestamps, and speaker attributionPulls primary literature, registrational trials, and conference proceedings on a clinical question, and structures the evidence with named citations and strength-of-evidence ratings.
evidence_synthesis.md with linked citations and strength-of-evidence ratingsSimulates KOL panel responses to a discussion guide, using each KOL's published views and conference history to produce a synthesised transcript with per-speaker attribution and confidence.
simulated_adboard.md with per-KOL attributions and confidence rangesDrafts MIR responses, MSL briefings, publication first-drafts, and congress summaries from a brief plus the Medical Repository's structured evidence — every sentence linked to a source.
draft.docx with sentence-level citations back to sourceTwo columns, written plainly. If a buyer's data-science team asks "what are you doing under the hood," this is the answer.
OBI-HUI is not a replacement for Excel, your BI stack, or your CFO model. It sits between them and makes the connection auditable.
Promotional and non-promotional work cannot share data, agents, prompts, or audit trails. The separation is contractual, technical, and visible in the product — not a policy memo.
IQVIAFlatironSymphonySEER internal analog library, congress dataPubMedClinicalTrials.govregistries congress proceedings, internal medical literature, de-identified RWDThree representative results from pilot engagements. Numbers shown are illustrative ranges from in-flight programs — final figures shared under NDA on request.
A short, honest answer to each. Full security pack and architecture diagram available on request.